We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
+16.55%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.43B
AUM Growth
+$203M
Cap. Flow
+$23.3M
Cap. Flow %
1.63%
Top 10 Hldgs %
47.17%
Holding
186
New
16
Increased
59
Reduced
61
Closed
5

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.7M
2
ORCL icon
Oracle
ORCL
+$5.36M
3
PLD icon
Prologis
PLD
+$4.68M
4
OKTA icon
Okta
OKTA
+$3.46M
5
AEP icon
American Electric Power
AEP
+$2.54M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$4.32M
2
TROW icon
T. Rowe Price
TROW
+$3.96M
3
AAPL icon
Apple
AAPL
+$3.38M
4
HAS icon
Hasbro
HAS
+$2.96M
5
RTX icon
RTX Corp
RTX
+$2.86M

Sector Composition

Rank Sector Weight
1 Consumer Staples 33.24%
2 Technology 16.25%
3 Healthcare 13.1%
4 Financials 10.83%
5 Consumer Discretionary 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TROW icon
101
T. Rowe Price
TROW
$23.9B
$2.98M 0.21%
24,100
-34,760
-59% -$3.96M
FDX icon
102
FedEx
FDX
$72.7B
$2.78M 0.19%
19,797
-200
-1% -$25.2K
AMT icon
103
American Tower
AMT
$80.8B
$2.47M 0.17%
9,545
– –
GS icon
104
Goldman Sachs
GS
$300B
$2.36M 0.17%
11,940
– –
ROST icon
105
Ross Stores
ROST
$80.5B
$2.29M 0.16%
26,900
-200
-0.7% -$18.1K
MA icon
106
Mastercard
MA
$502B
$2.14M 0.15%
7,250
+3,915
+117% +$1.1M
EPD icon
107
Enterprise Products Partners
EPD
$82.3B
$2.09M 0.15%
115,110
+32,000
+39% +$572K
VLO icon
108
Valero Energy
VLO
$90.1B
$2.05M 0.14%
34,900
-700
-2% -$41.8K
CSX icon
109
CSX Corp
CSX
$93.4B
$1.95M 0.14%
83,814
-3,699
-4% -$81.8K
PNC icon
110
PNC Financial Services
PNC
$99.7B
$1.92M 0.13%
18,220
– –
ALXN
111
DELISTED
Alexion Pharmaceuticals
ALXN
$1.91M 0.13%
+17,054
New +$1.81M
EOG icon
112
EOG Resources
EOG
$79.2B
$1.83M 0.13%
36,182
-631
-2% -$30.6K
BAC icon
113
Bank of America
BAC
$435B
$1.7M 0.12%
71,547
– –
PEP icon
114
PepsiCo
PEP
$190B
$1.64M 0.12%
12,406
– –
KLAC icon
115
KLA
KLAC
$239B
$1.38M 0.1%
71,000
– –
OTIS icon
116
Otis Worldwide
OTIS
$27.4B
$1.28M 0.09%
+22,482
New +$1.16M
DD
117
DELISTED
Du Pont De Nemours E I
DD
$1.2M 0.08%
22,631
-1,900
-8% -$101K
GE icon
118
GE Aerospace
GE
$374B
$1.13M 0.08%
33,107
+161
+0.5% +$5.43K
MDLZ icon
119
Mondelez International
MDLZ
$79.5B
$1.11M 0.08%
21,641
– –
QCOM icon
120
Qualcomm
QCOM
$155B
$1.09M 0.08%
12,000
+400
+3% +$32.1K
CARR icon
121
Carrier Global
CARR
$51B
$997K 0.07%
+44,865
New +$834K
WFC icon
122
Wells Fargo
WFC
$261B
$985K 0.07%
38,464
+3,400
+10% +$93K
SO icon
123
Southern Company
SO
$109B
$920K 0.06%
17,745
+2,180
+14% +$121K
ABBV icon
124
AbbVie
ABBV
$443B
$877K 0.06%
8,931
+2,031
+29% +$179K
COP icon
125
ConocoPhillips
COP
$147B
$870K 0.06%
20,700
– –
3 4
5
6 7

Similar funds

HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
MIM
Marco Investment Management Atlanta, Georgia $1.33B AUM 32.43% 1-Year Est. Return
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return

Cullinan Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Cullinan Associates held 186 positions worth $1.43B, up 17% from $1.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Cullinan Associates's Q2 2020 filing shows 16 new, 59 increased, 61 reduced and 5 closed positions. Its largest new stake was Okta: 20,400 shares worth $4.08M. The largest sale was Sanofi, an estimated $4.32M.

By sector, the portfolio is most concentrated in Consumer Staples at 33% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q2 2020 buy was Okta: 20,400 shares worth $4.08M.
  • Cullinan Associates added most to Amgen in Q2 2020, an estimated $28.7M increase.
  • Cullinan Associates's biggest Q2 2020 reduction was T. Rowe Price, cutting an estimated $3.96M.
  • Cullinan Associates fully exited Sanofi in Q2 2020, selling an estimated $4.32M.
  • Cullinan Associates's ten largest holdings make up 47% of its $1.43B portfolio in Q2 2020.
  • Cullinan Associates opened 16 new positions and closed 5 in Q2 2020.
  • Cullinan Associates's portfolio value rose 17% quarter-over-quarter to $1.43B.

Based on Cullinan Associates's 13F filing for Q2 2020, filed 7 Jul 2020.